rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-8-8
|
pubmed:abstractText |
Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocystis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neutrophil function and an immunosuppressive potential in lower doses could be speculated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0902-4441
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
72-3
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10914942-Adult,
pubmed-meshheading:10914942-Antimetabolites, Antineoplastic,
pubmed-meshheading:10914942-CD4-Positive T-Lymphocytes,
pubmed-meshheading:10914942-Cytarabine,
pubmed-meshheading:10914942-Fatal Outcome,
pubmed-meshheading:10914942-Fever,
pubmed-meshheading:10914942-Humans,
pubmed-meshheading:10914942-Immunocompromised Host,
pubmed-meshheading:10914942-Immunosuppression,
pubmed-meshheading:10914942-Leukemia, Erythroblastic, Acute,
pubmed-meshheading:10914942-Male,
pubmed-meshheading:10914942-Neutrophils,
pubmed-meshheading:10914942-Pneumonia, Pneumocystis,
pubmed-meshheading:10914942-Respiratory Insufficiency,
pubmed-meshheading:10914942-Sweet Syndrome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia.
|
pubmed:affiliation |
Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
|
pubmed:publicationType |
Journal Article,
Case Reports
|